Medlite ID: Supporting Patient Safety Initiatives to Reduce Healthcare Acquired Infections (HAIs)
The ongoing risks of healthcare-acquired infections (HAIs) are a significant patient safety concern prompting hospitals to seek new and innovative ways to reduce the risks of cross-contamination. Reducing HAIs across your healthcare organization can help improve patient care, reduce risk and increase staff efficiency.
Incorporating MedLite ID in your IV administrations can provide an important opportunity to decrease cross-contamination, improve clinician efficiency and positively impact the standard of patient care.
MedLite ID Tested Medical Tape: This Is What We Found
MedLite ID acquired multiple rolls of medical tape from a healthcare facility in order to conduct tests on the tape to understand the prevalence of pathogenic bacterial on medical tape commonly used to identify the primary medication infusion line.
Soft Cell Biological Research was asked to culture random rolls of tape used within a medical facility for bacteria and fungi. While bacteria are prevalent in all environments, multiple antibiotic resistant pathogens should be of concern within any healthcare facility.
All rolls were first inoculated to Mueller Hinton agar plates in a sterile manner, after which were submerged in separate sterile beakers filled with BHI broth and cultured for 24 hours before being plated to Mueller Hinton agar.
Of the identified bacteria, one, Acinetobacter_ursingii, was identified by the World Health Organization as critical and the second, Enterococcus faecium, was listed as serious. Roll B showed Staphyloccus epidermis, a microorganisim of the skin flor that can be very dangerous when it enters the bloodstream and cause potentially fatal complications.
80% of the used rolls tested positive for pathogens and 16 of the 36 bacteria and fungus found were pathogenic. Four of the five used rolls tested positive for a variety of pathogenic bacteria and the unused roll of tape produced non-pathogenic bacilli.
- Roll A cultured Bacillus hisashii, a non-pathogenic bacillus
- Roll B produced a Sulfa-Trimeth resistant Staphylococcus epidermidis, a known infector
- Roll C cultured Clostridium tertium, a known pathogen
- Roll D produced three bacterium including Clostridium tertium and Paenibacillus aceti-
both members of a class of bacteria known to be pathogenic in the immunocompromised
- Roll E cultured Enterococcus faecium, a dangerous pathogen
- Roll F, the new roll, handled in sterile conditions produced two non-pathogenic bacilli